Skip to main content

Table 6 Resistance rates(%) of Acinetobacter baumanii to antimicrobial agents

From: Bacterial resistance trends among intraoperative bone culture of chronic osteomyelitis in an affiliated hospital of South China for twelve years

Antimicrobial agent 2003–2004
(n = 0)
2005–2006
(n = 3)
2007–2008
(n = 6)
2009–2010
(n = 8)
2011–2012
(n = 17)
2013–2014
(n = 2)
Amikacin 66.7 66.7 50.0 64.7 100.0
Gentamicin 100.0 100.0 75.0 82.4 100.0
Piperacillin 100.0 66.7 75.0 88.2 100.0
Piperacillin/taazobactam 100.0 100.0 75.0 88.2 100.0
Cefazolin 100.0 100.0 100.0 100.0 100.0
Cefuroxime 100.0 100.0 100.0 100.0
Cefotaxime 100.0 80.0 75.0 82.4 100.0
Ceftazidime 100.0 60.0 50.0 76.5 50.0
Cefepime 100.0 100.0 50.0 70.6 50.0
Imipenem 33.3 16.7 50.0 64.7 100.0
Meropenem 100.0 0 80.0 75.0 100.0
Ciprofloxacin 100.0 83.3 62.5 70.6 100.0